Literature DB >> 9314075

Some macrophages kill Listeria monocytogenes while others do not.

S D Fleming1, P A Campbell.   

Abstract

It is not known why some macrophages can kill certain microbes, such as the facultative intracellular bacterium Listeria monocytogenes (L. monocytogenes), while other macrophages cannot. Perhaps listericidal activity is a property of macrophages at specific stages of differentiation; may be the ability to kill this bacterium is regulated by the microenvironment of the cell: or it is possible that other regulatory forces are important. We describe here three characteristics that distinguish macrophages which can kill L. monocytogenes from those which cannot. First, listericidal macrophages must have neither too much nor too little intracellular iron-they must have an intermediate amount. Second, the receptor a macrophage uses to phagocytose L. monocytogenes seems to influence the intracellular fate of this bacterium. And third, macrophages which have cell-surface interleukin-10 (IL-10), a known downregulator of macrophage function, cannot kill L. monocytogenes. These traits of macrophages and their effects on listericidal activity are reviewed here, and the possibility that these properties might interact to control macrophage bactericidal activity is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9314075     DOI: 10.1111/j.1600-065x.1997.tb00993.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  9 in total

Review 1.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice.

Authors:  Mayuka Horikawa; Eric T Weimer; David J DiLillo; Guglielmo M Venturi; Rosanne Spolski; Warren J Leonard; Mark T Heise; Thomas F Tedder
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

3.  Dissemination of Listeria monocytogenes by infected phagocytes.

Authors:  D A Drevets
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

4.  Severe Listeria monocytogenes infection induces development of monocytes with distinct phenotypic and functional features.

Authors:  Douglas A Drevets; Jennifer E Schawang; Vinay K Mandava; Marilyn J Dillon; Pieter J M Leenen
Journal:  J Immunol       Date:  2010-07-14       Impact factor: 5.422

5.  Localized reactive oxygen and nitrogen intermediates inhibit escape of Listeria monocytogenes from vacuoles in activated macrophages.

Authors:  Jesse T Myers; Albert W Tsang; Joel A Swanson
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

6.  Effect of acid adaptation on the fate of Listeria monocytogenes in THP-1 human macrophages activated by gamma interferon.

Authors:  Maria Pia Conte; Gloria Petrone; Assunta Maria Di Biase; Catia Longhi; Michela Penta; Antonella Tinari; Fabiana Superti; Giulia Fabozzi; Paolo Visca; Lucilla Seganti
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

7.  Hemolysin-positive enteroaggregative and cell-detaching Escherichia coli strains cause oncosis of human monocyte-derived macrophages and apoptosis of murine J774 cells.

Authors:  C Fernandez-Prada; B D Tall; S E Elliott; D L Hoover; J P Nataro; M M Venkatesan
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

8.  Alteration of pulmonary immunity to Listeria monocytogenes by diesel exhaust particles (DEPs). I. Effects of DEPs on early pulmonary responses.

Authors:  Xue-Jun Yin; Rosana Schafer; Jane Y C Ma; James M Antonini; David D Weissman; Paul D Siegel; Mark W Barger; Jenny R Roberts; Joseph K-H Ma
Journal:  Environ Health Perspect       Date:  2002-11       Impact factor: 9.031

9.  Modulation of Immune Functions by Foods.

Authors:  Shuichi Kaminogawa; Masanobu Nanno
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-06       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.